{"id":433283,"title":"Appendices: Handbook for health care professionals on biosimilar biologic drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:54:35.802000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs/handbook-healthcare-professionals/appendices.html","snippet":"Handbook for health care professionals on biosimilar biologic drugs: Appendices Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Glossary Definitions Glossary ADA anti-drug…","rawSnapshotUrl":"/api/snapshots/raw/433283","browseUrl":"https://replay.healtharchive.ca/job-6/20260102095435/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs/handbook-healthcare-professionals/appendices.html#ha_snapshot=433283","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}